Department of Pharmaceutics, Dalian Women and Children's Medical Group, Dalian, Liaoning, China.
College of Pharmacy, Dalian Medical University, Dalian, Liaoning, China.
Mol Genet Genomic Med. 2024 Jan;12(1):e2339. doi: 10.1002/mgg3.2339. Epub 2023 Dec 19.
Fructose-1,6-bisphosphatase (FBPase) deficiency, caused by an FBP1 mutation, is an autosomal recessively inherited metabolic disorder characterized by impaired gluconeogenesis. Due to the rarity of FBPase deficiency, the mechanism by which the mutations cause enzyme activity loss still remains unclear.
We report a pediatric patient with typical FBPase deficiency who presented with hypoglycemia, hyperlactatemia, metabolic acidosis, and hyperuricemia. Whole-exome sequencing was used to search for pathogenic genes, Sanger sequencing was used for verification, and molecular dynamic simulation was used to evaluate how the novel mutation affects FBPase activity and structural stability.
Direct and allele-specific sequence analysis of the FBP1 gene (NM_000507) revealed that the proband had a compound heterozygote for the c. 490 (exon 4) G>A (p. G164S) and c. 861 (exon 7) C>A (p. Y287X, 52), which he inherited from his carrier parents. His father and mother had heterozygous G164S and Y287X mutations, respectively, without any symptoms of hypoglycemia.
Our results broaden the known mutational spectrum and possible clinical phenotype of FBP1.
果糖-1,6-二磷酸酶(FBPase)缺乏症是一种常染色体隐性遗传代谢疾病,由 FBP1 基因突变引起,其特征为糖异生受损。由于 FBPase 缺乏症较为罕见,突变导致酶活性丧失的机制仍不清楚。
我们报告了一例儿科患者,其具有典型的 FBPase 缺乏症,表现为低血糖、高乳酸血症、代谢性酸中毒和高尿酸血症。采用外显子组测序寻找致病基因,Sanger 测序进行验证,并采用分子动力学模拟评估该新型突变如何影响 FBPase 的活性和结构稳定性。
直接和等位基因特异性分析 FBP1 基因(NM_000507)显示,先证者为 c. 490(外显子 4)G>A(p. G164S)和 c. 861(外显子 7)C>A(p. Y287X,52)复合杂合突变,分别来自其携带突变的父母。他的父亲和母亲分别携带杂合的 G164S 和 Y287X 突变,无任何低血糖症状。
我们的结果扩展了已知的 FBP1 突变谱和可能的临床表型。